[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100542643":3},{"organization":4,"armGroups":7,"interventions":17,"overallOfficials":24,"centralContacts":29,"locations":38,"responsibleParty":66,"collaborators":23,"id":68,"slug":69,"hasResults":70,"nctId":71,"briefTitle":72,"officialTitle":73,"acronym":23,"eligibilityCriteria":74,"healthyVolunteers":70,"sex":75,"minAge":76,"maxAge":23,"enrollmentInfo":77,"targetDuration":23,"studyType":80,"phases":81,"briefSummary":83,"conditions":84,"keywords":23,"overallStatus":57,"whyStopped":23,"lastUpdateSubmitDate":86,"lastUpdatePostDateStruct":87,"startDateStruct":90,"completionDateStruct":92,"leadSponsor":94,"locationsCount":95},{"fullName":5,"class":6},"University Hospital, Ghent","OTHER",[8,13],{"label":9,"type":6,"description":10,"interventionNames":11},"FAST-FORWARD schedule","The first group is treated according to the FAST-FORWARD schedule, consisting of 5 radiation sessions on 5 consecutive working days (e.g. Monday to Friday). 2 rest days are allowed in the schedule, so that the treatment lasts a maximum of 7 days.",[12],"Device: Questionnaire",{"label":14,"type":6,"description":15,"interventionNames":16},"HAI5 schedule","The second group is treated according to the HAI5 schedule, developed by the radiotherapy department of Ghent University Hospital. In this schedule, at least 1 day of rest is scheduled between each treatment session, so the treatment is administered over 10-14 days.",[12],[18],{"type":19,"name":20,"description":21,"armGroupLabels":22,"otherNames":23},"DEVICE","Questionnaire","Patients will be asked to complete questionnaires at different times (before, during and after radiation) to evaluate which schedule gives the fewest side effects and the best quality of life.\n\nThe basic questionnaire and questionnaire about early side effects will be completed weekly up to 6 weeks after radiotherapy. The questionnaire about late side effects will be completed: after 6 months, 1 year, 2 years, 3 years, 4 years and 5 years.",[9,14],null,[25],{"name":26,"affiliation":27,"role":28},"Liv Veldeman, MD, PhD","UZ Ghent","PRINCIPAL_INVESTIGATOR",[30,34],{"name":26,"role":31,"phone":32,"phoneExt":23,"email":33},"CONTACT","09 332 30 15","liv.veldeman@uzgent.be",{"name":35,"role":31,"phone":36,"phoneExt":23,"email":37},"Emma Van Damme","09 332 19 53","emma.vandamme@uzgent.be",[39,55],{"facility":40,"status":41,"city":42,"state":23,"zip":43,"country":44,"countryCode":45,"cosmosGeoPoint":46,"geoPoint":51,"contacts":52},"Universitary Hospital","NOT_YET_RECRUITING","Ghent","9000","Belgium","BE",{"type":47,"coordinates":48},"Point",[49,50],3.71667,51.05,{"lat":50,"lon":49},[53,54],{"name":26,"role":31,"phone":32,"phoneExt":23,"email":33},{"name":35,"role":31,"phone":36,"phoneExt":23,"email":37},{"facility":56,"status":57,"city":42,"state":23,"zip":43,"country":44,"countryCode":45,"cosmosGeoPoint":58,"geoPoint":60,"contacts":61},"University Hospital Ghent","RECRUITING",{"type":47,"coordinates":59},[49,50],{"lat":50,"lon":49},[62,64],{"name":35,"role":31,"phone":23,"phoneExt":23,"email":63},"Emma.VanDamme@uzgent.be",{"name":65,"role":28,"phone":23,"phoneExt":23,"email":23},"Liv Veldeman, Prof. dr.",{"type":67,"investigatorFullName":23,"investigatorTitle":23,"investigatorAffiliation":23,"oldNameTitle":23,"oldOrganization":23},"SPONSOR","100542643","fast-forward-vs-hai5-100542643",false,"NCT06345534","FAST-FORWARD vs HAI5","Randomized Comparison Between the FAST-FORWARD Schedule and the HAI5 Schedule for Breast Cancer Radiotherapy in 5 Fractions","Inclusion Criteria:\n\n* histopathological diagnosis of breast cancer\n* age 18 years or older\n* male or female\n* treated with breast conserving surgery or mastectomy with curative intent\n* multidisciplinary decision of adjuvant radiotherapy after surgery\n\nExclusion Criteria:\n\n* distant metastases\n* decision of preoperative radiotherapy\n* decision of partial breast irradiation\n* positive resection margins ('ink on tumour')\n* indication for boost on lymph node(s)\n* history of thoracic or ipsilateral axillary radiotherapy (including radiotherapy of the contralateral breast or chest wall)\n* need for bilateral irradiation\n* breast reconstruction or expander\n* patients unlikely to comply with the protocol (e.g. inability or unwillingness to complete the questionnaires at different time points).","ALL","18 Years",{"count":78,"type":79},740,"ESTIMATED","INTERVENTIONAL",[82],"NA","Randomized comparison between the FAST-FORWARD schedule and the HAI5 schedule for breast cancer radiotherapy in 5 fractions.",[85],"Cancer, Breast","2024-06-03",{"date":88,"type":89},"2024-06-05","ACTUAL",{"date":91,"type":89},"2024-05-30",{"date":93,"type":79},"2033-12-31",{"name":5,"class":6},2]